Melatonin has quietly become the default bedtime supplement in American households. Walk into any pharmacy and you’ll find it in gummies, tablets, sprays, and chocolate chews - often shelved near the children’s vitamins. The packaging rarely explains that melatonin isn’t a simple sleep aid. It’s a hormone that works as a timing signal for the body’s internal clock, and how you use it - and who’s using it - changes everything.
For adults crossing time zones or living with a diagnosed circadian rhythm disorder, melatonin has a real, if limited, evidence base. But for chronic insomnia, the major sleep-medicine guidelines don’t support it as a routine treatment. And for children? That’s where the gap between public use and what the evidence actually supports gets widest - and most consequential.
What Melatonin Actually Does#
Melatonin is a hormone produced by the brain in response to darkness. Its main job is regulating the circadian rhythm - your body’s internal clock that controls when you feel alert and when you feel sleepy (NCCIH: Melatonin - What You Need to Know). Light exposure at night, particularly blue light from screens, can suppress natural melatonin production and shift your sleep timing later.
This is why thinking about melatonin as a “timing signal” is more accurate than thinking about it as a sedative. It doesn’t knock you out the way a sleeping pill does. Instead, it tells your body what time it’s supposed to be. And because of that - timing your dose matters more than the milligram number on the bottle.
But here’s what makes the whole conversation more complicated: in the U.S., melatonin is sold as a dietary supplement, not a drug. The FDA does not review or approve dietary supplements before they hit the market (FDA: Questions and Answers on Dietary Supplements). Manufacturers are responsible for safety and labeling, and supplements cannot legally be marketed to treat, cure, or prevent disease. “OTC” doesn’t mean “FDA-approved like a prescription medication” - and for melatonin, that distinction matters more than most people realise.
Where the Adult Evidence Is Strongest: Jet Lag#
If melatonin has a clean win in the research, it’s jet lag. A systematic review found that melatonin can help prevent or reduce jet lag in adults crossing five or more time zones, especially when taken close to the target bedtime at the destination (Cochrane review: Herxheimer & Petrie, 2002). For an eastbound trip from the U.S. to Europe - where you’re trying to sleep earlier than your body thinks it is - that’s the scenario where the evidence lines up best.
But timing is everything. Take melatonin at the wrong moment - say, when your body clock isn’t ready for sleep - and you can end up with daytime drowsiness that makes the adaptation harder, not easier (Cochrane review: Herxheimer & Petrie, 2002). The same dose that helps when timed to the destination bedtime can backfire if you take it mid-flight while still on departure time.
So the jet lag takeaway isn’t “melatonin works for travel.” It’s more specific: for adults crossing multiple time zones, a short-term dose timed to destination bedtime has some systematic-review support. That’s not the same as a universal travel sleep aid - and it’s definitely not a licence for casual nightly use at home.
Delayed Sleep-Wake Phase Disorder: A Clinician’s Tool#
Beyond jet lag, the other adult use with guideline backing is delayed sleep-wake phase disorder - a circadian rhythm condition where someone’s natural sleep window is shifted much later than the social norm (think: can’t fall asleep until 2 or 3 a.m. consistently, not just night-owl preference). The American Academy of Sleep Medicine gives a “weak-for” recommendation for strategically timed melatonin in adults with DSWPD, and extends that to certain children and adolescents with the condition as well (AASM Clinical Practice Guideline: Circadian Rhythm Sleep-Wake Disorders).
The key word there is “strategically timed.” In DSWPD, melatonin is used at a specific time - often hours before the desired bedtime - to shift the circadian clock earlier. This isn’t the same as taking it right before bed because you’re wired. It’s a timing intervention that depends on knowing someone’s circadian phase. And a “weak-for” recommendation means it’s a reasonable option, not a must-do - the kind of decision a sleep specialist makes with a patient, not something to self-prescribe after reading a blog post.
Chronic Adult Insomnia: Where Guidelines Say No#
But here’s where things get complicated for the adult melatonin story. Despite melatonin’s popularity as an over-the-counter sleep aid, the evidence for chronic insomnia in adults is thin enough that the AASM’s 2017 clinical practice guideline suggests clinicians should not use melatonin for sleep-onset or sleep-maintenance chronic insomnia (AASM Clinical Practice Guideline: Chronic Insomnia, 2017).
What should be first-line for chronic insomnia? Cognitive behavioral therapy for insomnia - CBT-I. The American College of Physicians recommends CBT-I as the initial treatment for adults with chronic insomnia disorder, with medication considered only after CBT-I hasn’t worked and only through shared decision-making about benefits, harms, and costs (ACP Guideline: Management of Chronic Insomnia, 2016).
That’s a big gap between the public perception - melatonin as a natural, harmless sleep fix - and the guideline reality. Chronic insomnia is a different animal from a shifted body clock, and the major guidelines don’t blur that line. If you’ve been lying awake night after night for months, the evidence-based answer isn’t a gummy; it’s a structured behavioral program, ideally with a trained clinician.
The Rules Change for Children#
And now the section that probably matters most for families reading this: children.
Pediatric melatonin use has exploded in the U.S. CDC surveillance data tells a striking story: from 2012 to 2021, U.S. poison control centers recorded 260,435 pediatric melatonin ingestions - a 530% increase over the study period (CDC MMWR: Pediatric Melatonin Ingestions, 2012–2021). Most of these were unintentional ingestions in children aged 5 or younger. Hospitalizations and more serious outcomes also rose.
The trend line isn’t subtle - and it’s not just about parents giving melatonin on purpose. It’s about gummies and chewables sitting within reach, looking and tasting like candy.
The American Academy of Sleep Medicine’s health advisory on melatonin in children and adolescents sets down clear principles: talk to a pediatric health care professional before giving melatonin or any supplement to a child; many sleep problems can be addressed with schedule changes, habits, and behavioral strategies rather than supplements; and melatonin should be treated like medication - stored safely and kept out of children’s reach (AASM Health Advisory: Melatonin Use in Children and Adolescents).
NCCIH echoes that caution, noting that while some children’s sleep disorders are among the conditions where melatonin may help, there are real unknowns: limited studies, uncertainty about dose and timing, unresolved questions about long-term effects, and possible hormonal-development effects including impacts on puberty and menstrual cycles (NCCIH: Melatonin - What You Need to Know).
The Long-Term Question Nobody Can Answer Yet#
A 2023 review of pediatric melatonin use across 22 randomized studies with 1,350 patients found no short-term increase in serious adverse events - which is somewhat reassuring. But non-serious adverse events were more likely in the melatonin groups, and the evidence on pubertal development and bone health was very uncertain or completely absent (Systematic review: Händel et al., 2023).
Yet only one small follow-up study has looked at 51 children who’d used melatonin for an average of 3.1 years and didn’t find statistically significant differences in pubertal development, sleep quality, or mental health scores compared to Dutch norms (PubMed: van Geijlswijk et al., 2011). That’s worth knowing - but a sample of 51 kids with a mean follow-up of about 3 years doesn’t resolve the long-term safety question for broad pediatric use. The 2023 review’s bottom line is the honest one: we don’t yet know enough about puberty effects, and bone-health studies in children taking melatonin essentially don’t exist.
Product Quality: The Gummy Problem#
The pediatric safety concern isn’t only about melatonin itself - it’s also about what’s actually in the product. Multiple lab analyses have found that melatonin supplements frequently don’t match their labels. One study of 31 products found actual melatonin content ranging from 83% below to 478% above what the label claimed, and detected serotonin - a neurotransmitter with its own safety profile - in 8 of the 31 supplements (Erland & Saxena, 2017). The AASM advisory cites products ranging from less than half to more than four times the labeled amount, and notes that gummies and chewables are particularly relevant because children find them appealing (AASM Health Advisory: Melatonin Use in Children and Adolescents).
The practical takeaway: if a clinician does recommend melatonin for a child, the AASM suggests looking for products with a USP Verified Mark and starting with the lowest possible dose. But even that framing isn’t a DIY endorsement - it’s a reminder of why pediatric use needs clinician supervision in the first place.
Safety, Side Effects, and Interactions - For Everyone#
Melatonin isn’t a zero-side-effect substance just because it’s sold next to the vitamin C. For adults, the recognised side-effect list includes headache, dizziness, nausea, and daytime drowsiness - and Mayo Clinic specifically warns against driving or using machinery within five hours of taking it (Mayo Clinic: Melatonin - Drugs and Supplements). Less common effects can include vivid dreams or nightmares, irritability, confusion, mood changes, and stomach upset (Mayo Clinic: Melatonin Side Effects).
The medication interaction list is long. Mayo Clinic flags anticoagulants and antiplatelet drugs, anticonvulsants, blood pressure medications, diabetes medicines, CNS depressants, oral contraceptives, fluvoxamine, immunosuppressants, and drugs metabolised by the liver (Mayo Clinic: Melatonin - Drugs and Supplements). If you take any of these, the question shouldn’t be “is melatonin safe” - it should be “have I checked with my clinician or pharmacist.”
People with autoimmune disease should avoid melatonin unless specifically cleared by their doctor (Mayo Clinic: Melatonin - Drugs and Supplements). Pregnancy and breastfeeding? The available source material doesn’t give definitive safety data - which means the conservative default is to ask a clinician before using it.
Long-term safety is another open question. NCCIH is clear: short-term use appears safe for most people, but long-term safety information is lacking (NCCIH: Melatonin - What You Need to Know). And because melatonin is a hormone - not an inert nutrient - the long-term unknowns carry more weight than they would for, say, vitamin C.
Questions Worth Asking a Clinician#
If you’re considering melatonin - for yourself or for a child - here’s what should probably come up in a conversation with a health professional:
- Is the sleep problem actually a circadian timing issue, or could it be insomnia, sleep apnea, restless legs, anxiety, or something else that melatonin isn’t designed to address?
- For a child specifically: have we tried consistent bedtime routines, morning light exposure, screen curfews, and other behavioral strategies first?
- Do any of my current medications interact with melatonin?
- If I have an autoimmune condition, diabetes, blood pressure issues, or seizure history - does that change the risk calculation?
- Supposing a clinician recommends melatonin - what specific timing and product quality considerations apply?
Persistent or severe sleep symptoms - breathing pauses during sleep, chronic daytime exhaustion, mood changes - shouldn’t be self-managed with a supplement. Those are medical flags, and melatonin won’t make the underlying problem go away (NCCIH: Sleep Disorders and Complementary Health Approaches).
Bottom Line#
Melatonin has a legitimate, narrow lane. For adults with jet lag or a diagnosed circadian rhythm disorder, short-term, strategically timed use has some evidence behind it. For chronic adult insomnia, it’s not what the guidelines point to - CBT-I is. And for children, the gap between how widely melatonin is used and how much we actually know about long-term safety is wide enough that parents should slow down, talk to a pediatric clinician, and try behavioral sleep strategies first.
Think of melatonin as a clock-setting tool, not a bedtime sleeping pill. The evidence lives inside that distinction - and so does most of the safety margin.
